160 related articles for article (PubMed ID: 38300227)
1. Bacterial infection in endometriosis: a silver-lining for the development of new non-hormonal therapy?
Khan KN; de Ziegler D; Guo SW
Hum Reprod; 2024 Apr; 39(4):623-631. PubMed ID: 38300227
[TBL] [Abstract][Full Text] [Related]
2.
Muraoka A; Suzuki M; Hamaguchi T; Watanabe S; Iijima K; Murofushi Y; Shinjo K; Osuka S; Hariyama Y; Ito M; Ohno K; Kiyono T; Kyo S; Iwase A; Kikkawa F; Kajiyama H; Kondo Y
Sci Transl Med; 2023 Jun; 15(700):eadd1531. PubMed ID: 37315109
[TBL] [Abstract][Full Text] [Related]
3. New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments.
Brichant G; Laraki I; Henry L; Munaut C; Nisolle M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638843
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
[TBL] [Abstract][Full Text] [Related]
5. Pre- and postsurgical medical therapy for endometriosis surgery.
Chen I; Veth VB; Choudhry AJ; Murji A; Zakhari A; Black AY; Agarpao C; Maas JW
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003678. PubMed ID: 33206374
[TBL] [Abstract][Full Text] [Related]
6. Decrease of dysmenorrhoea with hormonal treatment is a marker of endometriosis severity.
Marcellin L; Bourdon M; Houdre D; Maignien C; Chardonnet AG; Borghese B; Mantelet LM; Santulli P; Chapron C
Reprod Biomed Online; 2023 May; 46(5):856-864. PubMed ID: 36959070
[TBL] [Abstract][Full Text] [Related]
7. Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.
Arosh JA; Lee J; Balasubbramanian D; Stanley JA; Long CR; Meagher MW; Osteen KG; Bruner-Tran KL; Burghardt RC; Starzinski-Powitz A; Banu SK
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9716-21. PubMed ID: 26199416
[TBL] [Abstract][Full Text] [Related]
8. Systemic antibiotics for treating diabetic foot infections.
Selva Olid A; Solà I; Barajas-Nava LA; Gianneo OD; Bonfill Cosp X; Lipsky BA
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009061. PubMed ID: 26337865
[TBL] [Abstract][Full Text] [Related]
9. Innovations in classical hormonal targets for endometriosis.
Pluchino N; Freschi L; Wenger JM; Streuli I
Expert Rev Clin Pharmacol; 2016; 9(2):317-27. PubMed ID: 26645363
[TBL] [Abstract][Full Text] [Related]
10. "Per vaginam" topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review.
Buggio L; Lazzari C; Monti E; Barbara G; Berlanda N; Vercellini P
Arch Gynecol Obstet; 2017 Sep; 296(3):435-444. PubMed ID: 28664485
[TBL] [Abstract][Full Text] [Related]
11. From pathogenesis to clinical practice: Emerging medical treatments for endometriosis.
Clemenza S; Sorbi F; Noci I; Capezzuoli T; Turrini I; Carriero C; Buffi N; Fambrini M; Petraglia F
Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():92-101. PubMed ID: 29559388
[TBL] [Abstract][Full Text] [Related]
12. Effects of minocycline and other antibiotics on Fusobacterium necrophorum infections in mice.
Kuck NA
Antimicrob Agents Chemother; 1975 Apr; 7(4):421-5. PubMed ID: 1147577
[TBL] [Abstract][Full Text] [Related]
13. Hormonal therapy for endometriosis: from molecular research to bedside.
Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
[TBL] [Abstract][Full Text] [Related]
14. Hormonal contraceptives and endometriosis/adenomyosis.
Schindler AE
Gynecol Endocrinol; 2010 Dec; 26(12):851-4. PubMed ID: 21067290
[TBL] [Abstract][Full Text] [Related]
15. State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials.
Mikuš M; Vitale SG; Ćorić M; Zajec V; Ciebiera M; Carugno J; D'alterio MN; Herman M; Puževski T; Angioni S
Gynecol Endocrinol; 2022 Nov; 38(11):911-917. PubMed ID: 36237165
[No Abstract] [Full Text] [Related]
16. Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for ovarian endometriosis.
Murakami M; Osuka S; Muraoka A; Hayashi S; Bayasula ; Kasahara Y; Sonehara R; Hariyama Y; Shinjo K; Tanaka H; Miyake N; Yoshita S; Nakanishi N; Nakamura T; Goto M; Kajiyama H
Reprod Biol Endocrinol; 2022 Mar; 20(1):58. PubMed ID: 35351143
[TBL] [Abstract][Full Text] [Related]
17. Histologic study of ovarian endometriosis after hormonal therapy.
Nisolle-Pochet M; Casanas-Roux F; Donnez J
Fertil Steril; 1988 Mar; 49(3):423-6. PubMed ID: 3125069
[TBL] [Abstract][Full Text] [Related]
18. Hormonal treatments for adenomyosis.
Fedele L; Bianchi S; Frontino G
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):333-9. PubMed ID: 17765017
[TBL] [Abstract][Full Text] [Related]
19. Different classes of antibiotics given to women routinely for preventing infection at caesarean section.
Williams MJ; Carvalho Ribeiro do Valle C; Gyte GM
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD008726. PubMed ID: 33661539
[TBL] [Abstract][Full Text] [Related]
20. Novel agents for the medical treatment of endometriosis.
Platteeuw L; D'Hooghe T
Curr Opin Obstet Gynecol; 2014 Aug; 26(4):243-52. PubMed ID: 24978852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
